C. Stephen Foster, M.D.
In Print (751-800)
751. Arcinue CA, Radwan A, Lebanan MO, Foster CS. Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyonagi-Harada syndrome. Ocul Immunol Inflamm. 2013;21(1):47-52.
752. Arcinue CA, Hochberg F, Neumann R, Foster CS. Diagnostic criteria for primary ocular lymphoma. 2013 Mar;120(3):646-646.e2.
753. Dick AD, Foster CS. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. 2013 Apr;120(4):777-87.
754. Arcinue CA, Ceròn OM, Foster CS. A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in Uveitis. J Ocul Pharmacol Ther. 2013 Jun;29(5):501-7.
755. Suelves AM, Arcinue CA, Gonazalez-Martin JM, Kruh JN, Foster CS. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease. 2013 Jun;120(6):1201-9.
756. Tauqir MZ, Shulman M, Bittencourt M, Sepah YJ, Ibrahim M, Do DV, Nguyen QD, Foster CS, Vora RA, Albini TA. Diagnostic and Therapeutic Challenges. Retina. 2013 Apr;33(4):883-8.
757. Foster CS. Les Manifestations d’Oculaire des Troubles Rhumatologique et Vasculaire Potentiellements Fatals. Journal Français d’Ophthalmologie, Vol. 36(6). June 2013.
758. Lightman S, Belfot R, Naik RK, Lowder C, Foster CS, Rentz AM, Cui H, Whitcup SM, Kowalski JW, Revicki DA. Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis. Invest Ophthalmol Vis Sci. 2013 Jul 18;54(7):4864-70.
759. Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kaçmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors. J Rheumatol. 2013 Aug;40(8):1394-403.
760. Radwan A, Metzinger JL, Hinkle DM, Foster CS. Cytomegalovirus Retinitis in Immunocompetent Patients: Case Reports and Literature Review Ocul Immunol Inflamm.2013 Aug;21(4):324-8.
761. Bajwa A, Foster CS. Diagnostic Testing of Primary Vitreo-Retinal Lymphoma. Journal of Analytical Oncology, Vol. 2(3). August 2013.
762. Yang P, Foster CS. Interleukin-21, Interleukin-23, and Transforming Growth Factor-β1 in HLA-A29-Associated Birdshot Retinochoroidopathy. Am J Ophthalmol. 2013 Aug;156(2):400-406.e2.
763. Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 2013 Aug;120(8):1571-9.
764. Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013 Sep;156(3):468-77.e2.
765. Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM, for the MUST Trial Research Group. Fluorescein Angiography versus Optical Coherence Tomography for Diagnosis of Uveitic Macular Edema. 2013 Sep;120(9):1852-9.
766. Sarup V, Foster CS.HLA Associations in Chronic Vision Threatening Uveitis. Semin Ophthalmol. 2013 Sep-Nov;28(5-6):333-6.
767. Metzinger JL, Foster CS. Emerging therapies for the treatment of uveitis: clinical trial observations. Clin Investigation. 2013 Oct; 3(10):951-66.
768. Saboo US, Metzinger JL, Radwan A, Arcinue CA, Parikh R, Mohamed A, Foster CS. Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report. J AAPOS. 2013 Oct;17(5):460-4.
769. Rodríguez-García A, Foster CS, González-Díaz MP, Larrazabal-Aguerrevere LI. Endoftalmitis Infecciosa Endógena Pediátrica: Reto Diagnóstico y Revisión de la Literatura. Rev Mex Infecc & Infectol. 2013 August ;33(4):174-82.
770. Metzinger JL, Cerón O, Foster CS. Recent Advances in Uveitic Glaucoma. Glaucoma Now, 2013 3.
771. Rashid KA, Foster CS, Ahmed AR. Identification of Epitopes within Integrin β4 for Binding of Autoantibodies in Ocular Cicatricial and Mucous Membrane Pemphigoid – Preliminary Report. Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7707-16.
772. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, English Edition, Issue 4.
773. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, English – Middle East Edition, Issue 4.
774. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, English – Indian Edition, Issue 3.
775. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, Italian Edition, Issue 4.
776. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, Spanish Edition, Issue 4.
777. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Vitreoretina (Spanish), Issue 3.
778. Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol. 2014 Jan;98(1):99-103.
779. Arafat SN, Suelves AM, Spurr-Michaud S, Chodosh J, Foster CS, Dohlman CH, Gipson IK. Neutrophil Collagenase, Gelatinase, and Myeloperoxidase in Tears of Patients with Stevens-Johnson Syndrome and Ocular Cicatricial Pemphigoid. Ophthalmology. 2014 Jan;121(1):79-87.
780. Kruh JN, Yang P, Suelves AM, Foster CS. Infliximab for the Treatment of Refractory Noninfectious Uveitis: A Study of 88 Patients with Long-Term Follow-Up. 2014 Jan;121(1):358-64.
781. Suelves AM, Siddique SS, Schurko B, Foster CS. Anterior chamber intraocular lens implantation in patients with a history of chronic uveitis: Five-year follow-up. J Cataract Refract Surg. 2014 Jan;40(1):77-81.
782. Hu-Torres S, Foster CS. Disease of the Year: Juvenile Idiopathic Arthritis – Differential Diagnosis. Ocul Immunol Inflamm. 2014 Feb;22(1):42-55.
783. Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema. 2014 Feb;121(2):588-95.e1.
784. Bajwa A, Foster CS. Ocular Manifestations of Systemic Lupus Erythematosus. J Clin Cell Immunol, 2014 Feb;5(1).
785. Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Factors predictive of remission of new-onset anterior uveitis. 2014 Mar;121(3):778-84.
786. Castiblanco C, Foster CS. Review of Systemic Immunosuppression for Autoimmune Uveitis. Ophthalmol Ther. 2014 Mar 18.
787. Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS. Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):2993-3002.
788. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza M, Foster CS. Clinical Features and Presentation of Posterior Scleritis: A Report of 31 Cases. Ocul Immunol Inflamm. 2014 Jun;22(3):203-7.
789. Wentworth BA, Freitas-Neto C, Foster CS. Management of Pediatric Uveitis . F1000Prime Rep. 2014; 6: 41.
790. Foster CS. Ocular Cicatricial Pemphigoid. Ophthalmolog Management, Special Report Cornea. 2014 Aug;18(8):8-9.
791. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Expert Opin Pharmacother. 2014 Oct;15(15):2141-54.
792. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. Expert Opin Biol Ther. 2014 Nov;14(11):1651-66.
793. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology. 2014 Oct;121(10):1855-62.
794. Bajwa A, Aziz K, Foster CS. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy. 2014 Nov;34(11):2259-68.
795. Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH. Periocular Corticosteroid Injections in Uveitis: Effects and Complications. 2014 Nov;121(11):2275-86.
796. Freitas-Neto CA, Cerón O, Pacheco KD, Pereira VO, Ávila MP, Foster CS. Optic Neuritis Complicating Herpes Zoster Opthalmicus in an Immunocompetent Patient. Revista Brasileira de Oftalmologia. 2014 Nov-Dec:73(6);386-388.
797. Freitas-Neto CA, Costa RA, Kombo N, Freitas T, Oréfice JL, Oréfice F, Foster CS. Subconjunctival Indocyanine Green Identifies Lymphatic Vessels. JAMA Ophthalmol. 2015 Jan;133(1):102-4.
798. Lou SM, Larkin KL, Winthrop K, Rosenbaum JT, and members of the Uveitis Specialists Study Group. Lack of Consensus in the Diagnosis and Treatment of Ocular Tuberculosis among Uveitis Specialists. Ocul Immunol Inflamm. 2015 Feb;23(1):25-31.
799. Freitas-Neto CA, Boonsopon S, Dhanireddy S, Maghsoudlou A, Silpa-Archa S, Foster CS. Birdshot retinochoroidopathy review. Arq Bras Oftalmol. 2015 Jan-Feb;78(1):56-61.
800. Boonsopon S, Maghsoudlou A, Foster CS. Ocular Manifestations in Systemic Lupus Erythematosus. Rheumatology (Sunnyvale). 2015 Mar; 5(1).
 |
|
|
|
